Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Rule 8.1-Torex Retail-Replace

21 Jun 2005 12:44

Evolution Securities21 June 2005 The 'Rule 8 - Torex Retail PLC' announcement released today at 11.55 under RNS No 8332N has been amended. The paragraph under the Amount bought column relating to the Trade Amendment was omitted. The full amended text is shown below. FORM 8.1 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of The City Code on Takeovers and Mergers) Name of purchaser/vendor * EVOLUTION SECURITIES LIMITED Company dealt in TOREX RETAIL Relevant security dealt in ORD Name of offeree/offeror with which associated TOREX RETAIL Specify category and nature of associate status # ADVISOR/BROKER - CATEGORY 2 Date of dealing 20 JUNE 2005 DEALINGS + Amount bought Price per unit (currency must be stated)127,350 105.00P 8,000 106.50P300,000 107.00P Trade Amendment from 17/06/05:127,200 at 105.00p now 127,188 at 105.00p Amount sold Price per unit (currency must be stated) 4,642 106.10P 2,950 106.40P373,100 107.00P 1,478 107.10P 3,400 108.00P Resultant total amount and percentage of the same relevant security owned or controlled -10,472 (-0.005%) IS A SUPPLEMENTAL FORM 8 (DERIVATIVE)/FORM 8 (OPTION) ATTACHED? NO Date of disclosure 21 JUNE 2005 Contact name DINA PATEL Telephone number 020 7071 4449 * Specify the owner or controller in addition to the person dealing. The naming of nominees or vehicle companies is insufficient. In the case of disclosure of dealings by fund managers on behalf of discretionary clients, the clients need not be named.# See the definition of "associate" in the Definitions Section of the Code.+ If disclosing dealings/holdings in derivatives or options, please attach Supplemental Form 8 (Derivative) or Supplemental Form 8 (Option), as appropriate. For details of the Code's dealing disclosure requirements, see Rule 8 and itsNotes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Feb 20251:46 pmRNSForm 8.3 - Tissue Regenix Group PLC
20th Feb 20259:00 amRNSForm 8.5 (EPT/NON-RI)
19th Feb 20259:26 amRNSForm 8.5 (EPT/NON-RI)
18th Feb 202510:07 amRNSForm 8.5- Tissue Regenix Group Plc
17th Feb 20259:38 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20252:16 pmRNSForm 8.3 - Tissue Regenix Group PLC
11th Feb 202511:11 amRNSForm 8.3 - Tissue Regenix Group PLC
5th Feb 202512:45 pmRNSForm 8.3 - Tissue Regenix Group PLC
4th Feb 202511:58 amRNSForm 8.3 - Tissue Regenix Group PLC
3rd Feb 202512:08 pmRNSForm 8.3 - Tissue Regenix Group PLC
31st Jan 20251:34 pmRNSForm 8.3 - Tissue Regenix Group PLC
31st Jan 20258:55 amRNSForm 8.5- Cavendish Securities PLC
30th Jan 20257:00 amRNSFull year trading update
24th Jan 202511:55 amRNSForm 8.3 - Tissue Regenix Group PLC
24th Jan 202510:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 20252:01 pmRNSForm 8.3 - Tissue Regenix Group PLC
15th Jan 20253:21 pmRNSForm 8.3 - Tissue Regenix Group plc
15th Jan 20251:25 pmRNSHolding(s) in Company
14th Jan 20252:02 pmRNSForm 8.3 - Tissue Regenix Group plc
14th Jan 20251:17 pmRNSForm 8.3 - Tissue Regenix Group PLC
13th Jan 20252:20 pmRNSHolding(s) in Company
13th Jan 20251:34 pmRNSForm 8.3 - Tissue Regenix Group PLC
9th Jan 20252:50 pmRNSForm 8.3 - Tissue Regenix Group PLC
8th Jan 20251:09 pmRNSForm 8.3 - Tissue Regenix Group PLC
8th Jan 20259:41 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 202510:59 amRNSForm 8.5 (EPT/NON-RI)
3rd Jan 202511:23 amRNSForm 8.5 (EPT/NON-RI)
2nd Jan 202512:38 pmRNSForm 8.3 - Tissue Regenix Group PLC
16th Dec 20242:31 pmRNSForm 8.3 - Tissue Regenix Group PLC
16th Dec 20248:58 amRNSForm 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
13th Dec 202411:08 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202410:19 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 202411:16 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 202412:15 pmRNSForm 8.3 - Tissue Regenix Group PLC
9th Dec 20245:52 pmRNSForm 8.3 - Tissue Regenix Group plc
9th Dec 20242:44 pmRNSHolding(s) in Company
9th Dec 202411:35 amRNSForm 8.3 - Tissue Regenix Group PLC
6th Dec 20241:57 pmRNSForm 8.3 - Tissue Regenix Group plc
5th Dec 202412:04 pmRNSForm 8.3 - Tissue Regenix Group PLC
26th Nov 20247:00 amRNSExtended distribution agreement with Arthrex, Inc.
25th Nov 20249:30 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20249:16 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20249:22 amRNSForm 8.5 (EPT/NON-RI)
20th Nov 20242:07 pmRNSHolding(s) in Company
20th Nov 202411:16 amRNSForm 8.5 (EPT/NON-RI)
20th Nov 202411:12 amRNSForm 8.3 - Tissue Regenix Group plc
19th Nov 20248:38 amRNSForm 8.5 (EPT/NON-RI)
18th Nov 202412:43 pmRNSForm 8.3 - Tissue Regenix Group PLC
15th Nov 20248:45 amRNSForm 8.3 - Tissue Regenix Group plc
14th Nov 20249:19 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.